Tactiva Therapeutics

About:

Tactiva Therapeutics is a development stage immuno-oncology company

Website: http://tactivatherapeutics.com/

Top Investors: Panacea Venture, EFung Capital, Viventures

Description:

Tactiva Therapeutics is an Immuno-Oncology Company Utilizing an Innovative Approach to Adoptive Cell Therapy.

Total Funding Amount:

$35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Buffalo, New York, United States

Founded Date:

2016-01-01

Founders:

Kunle Odunsi, Richard C. Koya

Number of Employees:

11-50

Last Funding Date:

2018-12-03

IPO Status:

Private

Industries: